SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-005197
Filing Date
2018-06-08
Accepted
2018-06-08 16:06:25
Documents
51
Period of Report
2018-04-30

Document Format Files

Seq Description Document Type Size
1 10-Q bpmx-20180430x10q.htm 10-Q 1389024
2 EX-31.1 bpmx-20180430ex3113f7863.htm EX-31.1 19272
3 EX-31.2 bpmx-20180430ex3129cfafb.htm EX-31.2 19279
4 EX-32.1 bpmx-20180430ex321fb421b.htm EX-32.1 11466
  Complete submission text file 0001558370-18-005197.txt   4885442

Data Files

Seq Description Document Type Size
5 EX-101.INS bpmx-20180430.xml EX-101.INS 972124
6 EX-101.SCH bpmx-20180430.xsd EX-101.SCH 35156
7 EX-101.CAL bpmx-20180430_cal.xml EX-101.CAL 31750
8 EX-101.DEF bpmx-20180430_def.xml EX-101.DEF 129831
9 EX-101.LAB bpmx-20180430_lab.xml EX-101.LAB 307661
10 EX-101.PRE bpmx-20180430_pre.xml EX-101.PRE 247794
Mailing Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025
Business Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: 10-Q | Act: 34 | File No.: 001-37411 | Film No.: 18889500
SIC: 2834 Pharmaceutical Preparations